Neurosense Therapeutics stock was originally listed at a price of $ in Dec 9, If you had invested in Neurosense Therapeutics stock at $, your. NeuroSense Therapeutics Ltd. Ordinary Shares - NRSN STOCK NEWS Welcome to our dedicated page for NeuroSense Therapeutics Ltd. Ordinary Shares news (Ticker. Neurosense Therapeutics Ltd. (NRSN) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is focused on discovering and developing treatments for patients suffering. Neurosense Therapeutics Ltd ; Previous Close: ; Open: ; Volume: 9, ; 3 Month Average Trading Volume: ; Shares Out (Mil):
NeuroSense Therapeutics Ltd. Wt. NRSNW (U.S.: Nasdaq). AT CLOSE PM EDT 05/20/ $USD; %. Volume62, Volume62, 65 Day Avg Vol9, View the NRSN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Neurosense Therapeutics. Neurosense Therapeutics Ltd NRSN:NASDAQ ; Open ; Day High ; Day Low ; Prev Close ; 52 Week High NeuroSense Therapeutics (NASDAQ:NRSN) Stock Quotes, Forecast and News Summary ; 52 Wk Range, - ; Market Cap, $M ; P/E Ratio, - ; Dividend Yield, -. NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense" or the "Company"), a late-clinical stage biotechnology company developing novel treatments for. NRSN NeuroSense Therapeutics Ltd. 3, Market Cap, $M. Volume, , Wk High, $ Wk Low, $ Find the latest NeuroSense Therapeutics Ltd. (NRSNW) stock quote, history, news and other vital information to help you with your stock trading and. Avoid hidden fees on international transfers when withdrawing from trading platforms. When investing in international stocks, you'll likely need to send money. NeuroSense develops combined therapies to treat complex neurodegenerative diseases. In addition to PrimeC for ALS, which is currently undergoing clinical. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. NRSN will report earnings. About NeuroSense Therapeutics Ltd (NRSN) ; Avg. daily volume. K ; EBITDA (TTM). — ; Open. $ ; Price / earnings ratio. x ; Today's range. $ - $
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating. NRSN | Complete NeuroSense Therapeutics Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. NeuroSense Therapeutics is a clinical-stage drug development company, advancing a groundbreaking treatment for people living with ALS, as well as other. The average one-year price target for NeuroSense Therapeutics Ltd. is $ The forecasts range from a low of $ to a high of $ A stock's price. The average price target for Neurosense Therapeutics Ltd. is $ This is based on 1 Wall Streets Analysts month price targets, issued in the past 3. NeuroSense Therapeutics Ltd. NASDAQ: NRSN is an Israel-based clinical-stage pharmaceutical company focused on drug development and treatment for Amyotrophic. Discover real-time NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) stock prices, quotes, historical data, news, and Insights for informed trading and. The week high for NeuroSense Therapeutics Ltd. Stock is $ and the week low is $ Performance ; Neurosense Therapeutics (NRSN). , , , ; BSE Sensex · , , ,
SECTOR, INDUSTRY, ACTIVITY ; Healthcare, Biotechnology & Medical Research, Bio Therapeutic Drugs. Stock ; Open. $ ; Change. -$ (%) ; Day's Range. $ - $ ; Week Range. $ - $ ; Volume. K. Research NeuroSense Therapeutics' (Nasdaq:NRSN) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth. NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating. The last closing price for NeuroSense Therapeutics was $ Over the last year, NeuroSense Therapeutics shares have traded in a share price range of $ to.
Real-time share price updates and latest news for NeuroSense Therapeutics Ltd (NASDAQ:NRSN) You can hold this stock in a SIPP, ISA, JISA and Trading Account. NeuroSense Therapeutics Ltd. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to its. Valuation: NeuroSense Therapeutics Ltd. ; P/E ratio * · EV / Sales * · Yield *. As of Aug the stock price of NeuroSense Therapeutics is $ What is the current market cap of NeuroSense Therapeutics? The current market. News for NeuroSense Therapeutics Ltd. Registered Shs ; 25d. NeuroSense Reports month Results From PARADIGM Phase IIb Study - Quick Facts ; 48d. NeuroSense's.
Royal Dutch Shell B Stock | Applicant Tracking System Advantages